SNP-based Prediction of Recurrence Risk in Kidney Stone Patients
NCT ID: NCT04937192
Last Updated: 2022-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1300 participants
OBSERVATIONAL
2012-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese CKD-MBD Prevalence Survey (CRISS-MBD)
NCT04714918
Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes
NCT00173030
Super Chinese Nephrotic Syndrome Registration System (SUCCESS)
NCT03001934
Review of Kidney Biopsies of Dent Disease Patients
NCT02022189
Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease
NCT03201406
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Investigators hope to identify predictors for the kidney stone recurrence. This would allow the identification of a subpopulation of kidney stone patients that would benefit most from prevention measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kidney stone former
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Kidney stone former who the stone was removed completely.
* Ability to give informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiangya Hospital of Central South University
OTHER
Wuhan University Renmin Hospital
UNKNOWN
The Second Affiliated Hospital of Kunming Medical University
OTHER
Tianjin Medical University Second Hospital
OTHER
Shenzhen People's Hospital
OTHER
301 Hospital
UNKNOWN
Zhongda Hospital
OTHER
People's Hospital of Xinjiang
UNKNOWN
ZhuZhou Central Hospital
OTHER
Baoshan No.2 People's Hospital
UNKNOWN
Guangdong No.2 People's Hospital
UNKNOWN
Dehong People's Hospital
UNKNOWN
Second Affiliated Hospital of Guangzhou Medical University
OTHER
Jiangmen Central Hospital
OTHER
Huizhou Municipal Central Hospital
OTHER
Yongzhou Center Hospital
UNKNOWN
Longgang District People's Hospital of Shenzhen
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guohua Zeng
Vice president
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guohua Zeng, M.D.
Role: PRINCIPAL_INVESTIGATOR
The First Affiliated Hospital of Guangzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MRER2013-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.